Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/15/2022* 17:00 EST Earnings Call Q2 2023 -- -- --
08/16/2022* -- Results Q1 2023 -- -- --
11/15/2021 -- Results Q2 2022 -- -- --
11/15/2021 17:00 EST Earnings Call Q2 2022 -- -- --
08/16/2021 -- Results Q1 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 08/16/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade
 
4.00
2.00
1.00
 
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
No data available
Last Report Date 11/15/2021
Beat/Miss Upgrade
Return Since -41.67%
Last FQE 03/31/2022
Next FQE 06/30/2022

Profile

Edit
PetVivo Holdings Inc is an us-based biomedical device company that focuses on the licensing and commercialization of medical devices and therapeutics for pets suffering from osteoarthritis and other afflictions. The company focuses on developing its lead product, Kush, which is a veterinarian-administered joint injection for the treatment of osteoarthritis.
URL https://www.petvivo.com
Investor Relations URL N/A
HQ State/Province Minnesota
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Growth
Next Earnings Release Aug. 16, 2022 (est.)
Last Earnings Release Nov. 15, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-19.21%
-84.91%
320.0%
-70.24%
-12.16%
578.8%
-71.55%
-51.72%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-19.11%
31.34%
-93.87%
-26.61%
-93.62%
-94.68%
-42.31%
-47.01%
-85.93%
36.36%
-41.67%
-81.67%
-92.16%
-85.11%
-87.99%
-43.69%
-63.25%
--
--
--
--
--
--
61.84%
-65.47%
2.74%
33.33%
8.50%
78.15%
-24.74%
366.0%
-17.98%
95.53%
As of July 01, 2022.

Profile

Edit
PetVivo Holdings Inc is an us-based biomedical device company that focuses on the licensing and commercialization of medical devices and therapeutics for pets suffering from osteoarthritis and other afflictions. The company focuses on developing its lead product, Kush, which is a veterinarian-administered joint injection for the treatment of osteoarthritis.
URL https://www.petvivo.com
Investor Relations URL N/A
HQ State/Province Minnesota
Sector Healthcare
Industry Medical Devices
Equity Style Small Cap/Growth
Next Earnings Release Aug. 16, 2022 (est.)
Last Earnings Release Nov. 15, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

No data available
Symbol Dollars Invested % Weight
     
     
     
     
     
     
     
     
     
     

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter PETV Tweets